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Abstract 
Background and objectives: Regardless of the disease states that people suffer from, maintaining sexual function 
is an important indicator of quality of life. The objective of this review was to figure out the relationship between 
epilepsy, antiepileptic drugs (AEDs) and sexual dysfunction.
Results: In various epidemiological and clinical studies, epilepsy has been correlated with a reduction in sexual 
function. This sexual dysfunction is not always detected in epileptic patients until systematic efforts are put in place, 
as part of the assessment and treatment process. Therefore, precise evaluations of the incidence of treatment related 
sexual dysfunction in epileptic patients is still lacking.
Conclusions: This literature review concluded that sexual function is influenced by the pathophysiology of epilepsy, 
as well as through the use of AEDs. To maximize quality of care in patients with epilepsy and those patients with 
other disease states who receive AEDs, it is important to address the status of the patient’s sexual function as part of 
the initial routine assessment and with any treatment related follow-up. Minimizing the effects of AED related sexual 
dysfunction can be achieved by raising awareness among patients, providing education and training for physicians 
regarding sexual dysfunction and obtaining a baseline sexual history from the patient so are important recommenda-
tions. In addition, systematic studies are needed to explore the risk and mechanism of such treatment related side 
effects on sexual function.
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Background
Historically discussion around sexual practices and asso-
ciated dysfunction was taboo. However, in the modern 
era, awareness of issues associated with sexual dysfunc-
tion has been more commonly aired. Western civilization 
has become more open-minded about discussing sexual 
dysfunction, and in particular about erectile dysfunction 
(ED) in men, often associated with chronic disease. With 
this opening up of society there has been encouragement 
for people to think about their sexual performance and 
to seek advice from health consultants (Laumann et  al. 
1999; Kaufman et al. 2015).
The very first orally available drug for male ED was 
sildenafil (Viagra) which not only treated the problem 
but also through marketing campaigns, increased aware-
ness among people. These days ED is considered amongst 
the general public to be a “medical condition” that can 
be managed. In terms of etiology both physical (ED in 
men due to circulatory disorders) and psychological fac-
tors (inadequate interpersonal associations, psychiatric 
illness) are responsible for sexual dysfunction. Another 
cause of sexual dysfunction is the use of drugs such as 
anti-hypertensive (Fogari et  al. 1998), anti-psychotics 
(Baldwin and Birtwistle 1997), anti-depressants (Bald-
win et al. 1997; Goldstein and Goodnick 1998) and anti-
epileptic drugs (AEDs) (Hamed et al. 2015; Kirmani et al. 
2014; Lombardi et al. 2015; Meryn 2015; Svalheim et al. 
2015; Urso et al. 2014; Kaufman et al. 2015; Sivaraaman 
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and Mintzer 2011; Kaufman and Struck 2011b). The link 
between sexual dysfunction and drug induced as opposed 
to disease induced effects is complicated, and the case of 
epilepsy and AEDs has received less attention than one 
might expect. Sexual dysfunction may impact on compli-
ance and is reported to be dose dependent with various 
AEDs (Kaufman and Struck 2011a). For example, case 
reports of gabapentin-induced sexual dysfunction sug-
gest that the minimum total daily dose required for sex-
ual dysfunction is 900 mg (Dalal and Zhou 2008; GRANT 
and OH 2002).
The human sexual response and sexual 
dysfunction
Natural sexual response of a human can be divided into 
four stages and disturbance can occur in any one these 
stages;
1. Desire typically this consists of fantasies about, and 
the desire to have, sexual activity.
2. Excitement the individual sense of sexual enjoyment, 
associated with physiological alterations, including 
penile tumescence and erection in men, and pel-
vic vasocongestion, inflamed external genitalia, and 
lubrication and extension of the vaginal canal in 
women.
3. Orgasm height of sexual enjoyment, by the discharge 
of sexual tension and rhythmic contraction of per-
ineal muscles as well as reproductive organs.
4. Resolution sense of comfort and muscular leisure. 
Physiologically men are noncompliant to erection 
and orgasm for a varied time period, while women 
might be capable to respond to additional stimula-
tion.
The label ‘sexual dysfunction’ has been classified in 
the International Classification of Mental and Behav-
ioral Disorders, 10th edition (ICD-10) (World Health 
Organization 1992) (for those people who were incapable 
of enjoying their sexual relationship as they want). The 
ICD-10 sexual dysfunction categorization is not based on 
organic pathophysiology or infection. Both ICD-10 and 
Diagnostic and Statistical Manual of Mental Disorders, 
fourth edition (DSM-IV) (American Psychiatric Asso-
ciation 2000) utilized the same classificatory proposal 
(Table 1).
Men and women can both suffer from sexual dysfunc-
tion the difference being women tend to express a lack 
of sexual enjoyment and/or interest, whilst men face 
sexual dysfunction related largely to physical response 
including failure to achieve an erection and/or premature 
ejaculation (McCabe et  al. 2016). There has been dia-
logue to suggest that the categorical approaches to sexual 
dysfunction as defined by the ICD-10 and DMS-IV high-
light the obscure, diverse and exclusive approaches 
whereby any person or couple could share their sexual 
problems (Bancroft 2009). It is evident if any phase of 
sexual response is changed, other phases may also be 
affected. Therefore, for diagnosis and subsequent treat-
ment to be successful with sexual dysfunction it is essen-
tial to intervene with any relevant presenting complaint, 
rather than merely focusing on the standard diagnostic 
criteria.
Epidemiology of sexual dysfunction
The epidemiology of sexual dysfunction has not been 
broadly discussed in the literature; or at least the lit-
erature has not been reviewed and synthesized. Thirty 
years ago prevalence data for sexual dysfunction were 
derived according to the DSM-III by Nathan et al., who 
analyzed twenty two studies about sexual dysfunction 
in the general population. Methodological issues in this 
analysis indicated that an extensive estimation might be 
made (Nathan 1986). The incidence of reduction of sex-
ual desire was found to be 35% in women, 16% in men, 
premature ejaculation 35% and ED 10–20% in men and 
in female, orgasmic complication was found to be 5–15%. 
According to a study conducted in the United States 
(US), sexual dysfunction was more common in women 
(43%) than men (31%) (Laumann et al. 1999). In the case 
of women, low sexual desire (22% prevalence), arousal 
difficulty (14%) and sexual pain (7%) have been observed. 
Whilst for men premature ejaculation (21%), low sexual 
desire (5%) and ED (5%) have been observed. Sexual dys-
function rates can be different depending upon the popu-
lation being studied and the nature of sexual dysfunction 
being evaluated. The data represented here demon-
strates a high prevalence of sexual dysfunction for both 
males and females (Christensen et  al. 2011; Ernst et  al. 
1993; Lindau et al. 2007; Hendrickx et al. 2016). Table 2 
Table 1 Standard classification system for sexual dysfunc-
tion
F52.0 Lack or loss of sexual desire
F52.1 Sexual aversion and lack of sexual enjoyment





F52.7 Excessive sexual drive
F52.8 Other sexual dysfunction, not caused by organic disorder or 
disease
F52.9 Unspecified sexual dysfunction, not caused by organic disorder 
or disease
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summarizes the key findings of studies published on sex-
ual dysfunction among the general population.
The major categories of sexual dysfunction are influ-
enced by various aspects. First, the means of enquiry and 
type of data reporting mechanism i.e. the occurrence 
of sexual dysfunction in one prospective study was 14% 
when relying on spontaneous self-reporting, but 58% 
when the doctor directly asked the patient about it (Mon-
tejo-Gonzalez et al. 1997). Second, the attitudes of peo-
ple with respect to disclosing and fully discussing their 
sexual dysfunction issues with their physician is strongly 
influenced by the culture of a society (Bhavsar and Bhu-
gra 2013).
To provide an example, this is especially the case with 
Muslim people whereby discussing anything sexually-
related, including issues like sexual dysfunction outside 
of marriage is prohibited. This can make it very difficult 
for Muslim clients to seek help from health profession-
als; however, there mechanisms in place where it may be 
allowed for treatment purposes (Sungur and Bez 2016). 
Any sexual activity outside of marriage is also banned 
under Islam, but the religion encourages the enjoyment 
of sex and sensitivity to the needs of the spouse within 
heterosexual marriages. Therefore, it is critical for health 
professionals to be aware of the role of culture in defin-
ing sexual dysfunction and how cultural factors can be 
considered when initiating treatment as well as in ther-
apeutic engagement and alliance between patient and 
practitioner.
Third, sexual dysfunction can be defined in many terms 
and is reliant on the belief of what is usual or normal in 
a sexual relationship (Bhugra and de Silva 2007). Finally, 
temporal trends can occur with spikes in concern about 
disorders, as increased awareness of sexual matters and 
availability of medical treatments increase the numbers 
who perceive themselves as suffering from sexual dysfunc-
tion and come forward to seek treatment (Baldwin 2001).
Sexual dysfunction in epileptic patients
Epilepsy is a significant chronic neurologic disorder char-
acterized by episodes of seizure (of various types), which 
generally require lifelong management with medication 
Table 2 Studies of sexual dysfunction in the general population
Population Subjects (M/F) Dysfunctions assessed (%) References
40-year-old Danish women 0/324 Impaired interest (41.8), orgasmic difficulties (36.7), dissatisfac-
tion (35.4), pain/dyspareunia (1.3)
Garde and Lunde (1980)
35–59-years-old Oxford women 0/521 Impaired interest (17), orgasmic difficulties (16), pain/dys-
pareunia (8)
Osborn et al. (1988)
29-year-old men, 30-year-old women 197/218 Men dissatisfaction (21), impaired interest (7), premature 
ejaculation (4)
Ernst et al. (1993)
Women dissatisfaction (21), impaired interest (16), orgasmic 
difficulties (7), pain/dyspareunia (6)
Iranian women aged 20–60-years-old 0/2626 Orgasmic difficulties (37), low sexual desire (35), lubrication 
disorders (33.7), dissatisfaction (31.5), arousal disorders (30), 
pain/dyspareunia (26.7)
Safarinejad (2006)
US adults (57–85-years of age) 1455/1550 Men erectile difficulties (37), lack of interest in sex (28), climax-
ing too quickly (28), anxiety about performance (27), inability 
to climax (20)
Lindau et al. (2007)
Women lack of interest in sex (43), lubrication disorders (39), 
inability to climax (34), finding sex not pleasurable (23), pain 
(17)
British women aged 18–85-years-old. 0/1489 Low sexual desire (17.3), dissatisfaction (14.6), orgasmic dif-
ficulties (13.5), arousal disorders (13.3), lubrication disorders 
(11.5), pain/dyspareunia (11.5)
Burri and Spector (2011)
Danes aged 16–95-years-old 2120/2295 Men premature ejaculation (7), erectile dysfunction (5), anor-
gasmia (2), dyspareunia (0.1)
Christensen et al. (2011)
Women lubrication insufficiency (7), anorgasmia (6), dyspareu-
nia (3), vaginismus (0.4)
Swiss men aged 18–25-years-old 3886/0 Erectile dysfunction (29.9), premature ejaculation (11.4) Mialon et al. (2012)
Flemish men and women 14–80-years-old 651/695 Men erectile dysfunction (7.1), premature ejaculation (6.3), 
hyperactive sexual desire (3.3)
Hendrickx et al. (2016)
Women lubrication dysfunction (9.6), absent or delayed 
orgasm (7.4), low responsive sexual desire (6.9), low sponta-
neous desire (5.3)
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(Atif et  al. 2016). Children and adults are both affected 
by this disease. Approximately 1 in 26 people will develop 
epilepsy at some point in their lives (England et al. 2012). 
Sexual dysfunction associated with epilepsy is not yet 
completely understood (Harden 2008) and epilepsy is a 
complex disease causing several downstream pathologi-
cal alterations which may need further exploration and 
treatment. One manifestation of the disease includes 
endocrine disorders in men and women which influences 
the reproductive system. Reproductive endocrine dis-
orders in epileptic women include polycystic ovary syn-
drome (PCOS) (Bauer and Cooper-Mahkorn 2008; Bilo 
et al. 1988; Herzog et al. 2003a, b, 1984; Hopkinson et al. 
1998; Gorkemli et  al. 2008), hypothalamic amenorrhea 
(Bilo et  al. 2001; Herzog et  al. 1986b), hyperandrogen-
emia (HA) (Luef et al. 2002b; Löfgren et al. 2007), galac-
torrhea, hirsutism, menstrual abnormality and infertility 
(Bauer 2001; Bauer et al. 2002; Herzog et al. 2003b; Löf-
gren et  al. 2006). Sexual dysfunction impacts between 
one and two thirds (30–66%) of epileptic men (Blumer 
and Walker 1967; Hierons and Saunders 1966; Herzog 
et al. 1986a) and between 14 and 50% of epileptic women 
(Demerdash et al. 1991; Jensen 1992). Evidence suggests 
that (Edwards et al. 1999; Baird et al. 2003; Quigg et al. 
2002; Morrell et  al. 2005) patients with partial epilepsy 
(PE) are more severely affected by reproductive endo-
crine and sexual dysfunction than idiopathic generalized 
epileptic (IGE) patients, predominantly of temporal lobe 
origin (Table 3).
The underlying mechanism of reproductive dysfunc-
tion has various hypotheses. One of the most accepted 
hypotheses suggests that the activity of gonadotropin-
releasing hormone (GnRH) pulse generator is disturbed 
due to the temporal lobe regions associated with epilepsy, 
which might be the origin of paroxysmal release, just 
before the hypothalamus (Verrotti et  al. 2015). Ampli-
fication of the pulse frequency of GnRH and as a result 
the luteinizing hormone (LH) and follicle-stimulating 
hormone (FSH) ratio is related among PCOS patients 
(Rauchenzauner et al. 2014). The decrease in GnRH pulse 
frequency also lowers LH and estrogen (E2) levels, which 
an attribute is of HA. Moreover, several other aspects, 
such as, obesity, genetic disposition, laterality of epilepsy, 
type of AED prescribed, age and severity of seizures, 
might also be reasons for clinical expression of specific 
reproductive disorders i.e. HA, PCOS, ovulation, hir-
sutism (Verrotti et al. 2011).
The relationship between sexual dysfunction 
and AEDs
Seizure disorders are linked with sexual dysfunction as 
part of the pathophysiology, whilst all the available AEDs 
have not yet been definitively proven to have negative 
impacts on sexual function. As such, evaluation of AED-
induced sexual dysfunction is complicated and less than 
clear (Crenshaw and Goldberg 1996; Gitlin 2003). Com-
parative analyses of AEDs in patients with epilepsy, 
inducing sexual dysfunction are hard to find. The enzyme 
stimulating AEDs (phenytoin, topiramate, phenobarbital, 
oxcarbazepine and carbamazepine) raise hepatic synthe-
sis of sex hormone binding globulin (SHBG) that lessens 
the accessibility of testosterone. Additionally, enhanced 
sex hormone metabolism and contraceptive hormones 
are not found with the use of AEDs that do not stimulate 
hepatic enzymes (e.g. lamotrigine, valproate, gabapentin, 
and vigabatrin) (Herzog et al. 2005; Morrell 2003). A con-
sistent finding in the literature is that sexual dysfunction 
occurs with greater prevalence in patients taking pheny-
toin and carbamazepine than in patients taking valproate 
or lamotrigine (Herzog et al. 2005; Gutierrez et al. 2008). 
Women treated with valproate for bipolar disorder have 
also been reported to have severely decreased libido and 
anorgasmia, while there are case reports of gabapentin-
associated anorgasmia in women who suffer from epi-
lepsy (Harden 2005). A review of pregabalin efficacy and 
tolerability makes no mention of sexual dysfunction as 
an observed adverse effect (Tassone et al. 2007). Several 
studies in men and women have indicated that AEDs are 
related to sexual dysfunction (Table 4).
Antiepileptic drugs, epilepsy and serum sex 
hormones
Sex hormones levels contribute to sexual dysfunction 
as well as other reproductive disorders and these levels 
can be change as a result of the administration of AEDs 
(Table  5) (Morrell et  al. 2005). The reproductive endo-
crine system may also be influenced by the pathophysi-
ological effects of epilepsy as a disease in its own right 
(Scharfman et al. 2008). Endocrinological alterations due 
to epilepsy can be postulated in spite of the complicated 
interconnection among the limbic system and the hypo-
thalamic–pituitary axis (HPA). Production toward HPA 
from the limbic cortex, containing nuclear configuration 
inside the amygdale, can alter key features in the dis-
charge of sex hormones. Reproductive functions and dis-
charge of sex hormones are affected by the influence of 
epilepsy in the medial temporal lobe region of the brain 
(Herzog et al. 1986b). Though the complexity it remains 
uncertain as to whether hormonal irregularity is because 
of epilepsy associated HPA dysfunction or whether it is 
due to the side effects of AEDs (Verrotti et al. 2011). The 
role of the HPA, the production of LH and FSH, GnRH, 
prolactin (PRL), and the end products of metabolism and 
their concentrations i.e. E2, T (testosterone), and DHEAS 
(dehydroepiandrosterone), are altered in epileptic women 
(Table 5) (Morrell 2003; Genton et al. 2001).
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Treatment of sexual dysfunction
Appropriate treatment to be provided for epilep-
tic patients with sexual dysfunction requires evalu-
ation according to patient requirements, epileptic 
condition and comorbidities and the medicines avail-
able for managing epilepsy. Various approaches might be 
helpful for treatment of sexual dysfunction in epileptic 
patients including;
  • Behavioral approaches to enhance sexual perfor-
mance.
  • Waiting for tolerance to develop.
  • Dose reduction of current medicines.
  • Drug administration delayed until after sex.
  • Adjuvant treatment of the sexual dysfunction per se.
  • Varying the diverse range of antiepileptic’s available 
for individual patients.
Several adjuvant medicines i.e. buspirone, yohimbine, 
neostigmine, cyproheptadine, mianserin, amantadine 
and dexamphetamine, are used to cure AEDs related 
sexual dysfunction (Shapira 2003). ED in men can be 
treated by using indicative approaches in combination 
with previously described treatment approaches. This 
might include corporal initiation of the penis to stimu-
late spinal reflexes, and loss of blood can be prevented 
by inserting elastic constricting bands at the base, and 
negative pressure facilitating cavernous blood flow 
Table 3 Studies of epilepsy type and sexual and reproductive dysfunction
PCO polycystic ovaries, HA hyperandrogenism, PCOS polycystic ovary syndrome, IGE idiopathic generalized epilepsy, PE partial epilepsy, F female





PE F (99) i. 17.9%
ii. 27.8%
iii. 38.5%
Questionnaire Morrell and Guldner (1996)





PE F (99) i. 72.2%
ii. 15.4%
Questionnaire Lambert (2001)
IGE F (17) i. 84.2%
ii. 7.6%
Erectile dysfunction GTCS M (25) 72% Questionnaire Nikoobakht et al. (2007)
PE M (16) 32%
Erectile dysfunction PE M (418) 25.8% Clinical interview Keller et al. (2012)










Clinical examination, transvaginal ultrasonography Löfgren et al. (2007)







IGE F (52) i. 23%
ii. 5.8%
iii. 25%
Clinical examination, transvaginal ultrasonography Luef et al. (2002a)
PE F (40) i. 42.5%
ii. 2.5%
iii. 37.5%
PCO IGE F (36) 21% Suprapubic ovary ultrasound Murialdo et al. (1997)










Clinical examination Demerdash et al. (1991)
PE F (106)
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generated by using vacuum devices (Guldner and Mor-
rell 1996). Additionally, methods such as the intercav-
ernosal injection of vasodilators, i.e. papaverine or a 
grouping of papaverine, phentolamine, and prostaglan-
din E1, or yohimbine can be used to treat ED (Smaldone 
et al. 2004; Rokkas 2015). Other pharmaco-therapies for 
combatting ED to enhance the quality and frequency of 
erection include; topical nitroglycerine, topical minoxidil, 
and sildenafil (Rokkas 2015). The authors are not aware 
of any research that has been conducted on the use of 
sildenafil for ED in epileptic patients. Phosphodiester-
ase type-5 inhibitor drugs are now the first-line treat-
ment for ED (Shamloul and Ghanem 2013; Bruzziches 
et al. 2013; Lee et al. 2015). Selective serotonin reuptake 
inhibitors (for example; escitalopram, paroxetine, fluox-
etine, sertraline, etc.) and topical anesthetic creams are 
available but are not approved for the ED indication. 
However, they still serve as effective off-label treatments 
for premature ejaculation (Stimmel and Gutierrez 2006). 
Testosterone and aromatase inhibitors have been used 
in the investigational setting to treat sexual dysfunction 
in men taking AEDs (Hamed et al. 2013). Patient educa-
tion and follow-up appointments are essential to ensure 
the optimal outcomes of pharmacologic treatment for 
sexual dysfunction in the epileptic patient. There are no 
approved pharmacologic treatments for female hypoac-
tive sexual desire disorder or female orgasmic disorder. 
However, female sexual arousal disorder is treated with 
either estrogen replacement therapy or vaginal lubricants 
(Gutierrez et al. 2008).
Conclusions and recommendations
Sexual dysfunction in the epileptic patient is complex 
as it is often difficult to determine whether the dys-
function is disease or treatment related. There is a scar-
city of data on the occurrence of sexual dysfunction 
Table 4 Anti-epileptic drugs associated with sexual dysfunction
GTCS generalized tonic–clonic seizure, PE partial epilepsy, IGE idiopathic generalized epilepsy
Drug and dose (mg) Dysfunction 
assessed




Primidone (250) Decreased libido or 
impotence
M (109) 22% GTCS Questionnaire Mattson et al. (1985)
Carbamazepine (580) Sperm abnormality M (13) 77% IGE, PE Semen analysis and 
ultrasonography of 
testicles
Isojärvi et al. (2004)
Oxcarbazepine (1060) M (17) 59%
Valproate (1080) M (25) 80%
Topiramate (100–200) Erectile dysfunction M (40) 5% PE Clinical interview Holtkamp et al. (2005)




iv. Diminished sexual 
desire




GTCS Sexual function ques-
tionnaire
Hamed et al. (2006)
Carbamazepine 
(400–1000)




Pregabalin (150–600) Erectile dysfunction M (363) 3.0% PE Questionnaire Hitiris et al. (2006)
Lamotrigine (50–200) Lack of sexual interest M (75), F (66) 11% Complex PE, IGE Changes in sexual 
functioning ques-
tionnaire (CSFQ)
Gil-Nagel et al. (2006)
Phenytoin (100) Retrograde ejaculation M (1) Case report PE Clinical examination Elia et al. (2010)
Zonisamide (200) Erectile dysfunction M (1) Case report PE Clinical interview Maschio et al. (2011)






M (2) Case reports GTCS, Myoclonic 
seizures
Clinical interview Calabrò et al. (2012)
Pregabalin (300) Anorgasmia M (4) Case reports PE Clinical interview Calabrò et al. (2013)
Leviteracetam 
(500–1000)
Sperm abnormality M (10) 69.2% GTCS, complex PE Computer-aided 
sperm analysis
Xiaotian et al. (2013)
Valproate (500–1000) M (15) 18.8%
Lacosamide (400) i. Loss of libido
ii. Erectile dysfunction
M (1) Case report Simple and complex 
seizures
Clinical examination Calabro (2016)
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among the population as a whole and amongst those 
taking AEDs which can induce sexual dysfunction. This 
is a broad review looking at sexual dysfunction but the 
primary aim is to better understand the literature sur-
rounding sexual dysfunction in the epileptic patient 
where both the pathophysiology and the treatment 
can cause a degree of sexual dysfunction. This review 
concluded that the most common sexual dysfunc-
tion in males is ED and early ejaculation while females 
complain of lack of interest in sex and failing to reach 
orgasm.
Epilepsy is associated with sexual dysfunction while 
it is not yet known whether all AEDs have a negative 
impact on sexual function. Unraveling the causations of 
AED-induced sexual dysfunction in the epileptic patient 
is complicated. Sex hormone levels can be changed due 
to AEDs which are the cause of sexual dysfunction and 
reproductive disorders. Systematic studies are needed 
to explore the risks and mechanisms of such treatment 
related side effects on sexual function; particularly in 
epileptics. This review lead to the following recommen-
dations for physicians in improving the management of 
sexual dysfunction for their patients: (1) improved elec-
tronic medical record template to include appropriate 
questions related to sexual dysfunction in appropriate 
populations such as epileptics; (2) revision of undergrad-
uate and residency curricula to include a broader appre-
ciation of the impact of illness processes, comorbidities, 
and associated pharmacotherapies upon sexual function-
ing; and (3) required continuing medical education on 
sexual dysfunction.
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